
April 29, 2020 Research and Development Australia, COVID-19, China, coronavirus

April 29, 2020 Research and Development BARDA, COVID-19, coronavirus, hydroxychloroquine

April 29, 2020 Research and Development, Sales and Marketing Cosentyx, EU, Novartis, axial spondyloarthritis, pharma

April 28, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

April 28, 2020 Manufacturing and Production, Research and Development Janssen, NICE, Stelara, ulcerative colitis

April 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, feature, real world data, real world evidence, real-world data, real-world evidence

April 24, 2020 Medical Communications, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

April 23, 2020 Research and Development Jakavi, Novartis, pharrma

April 22, 2020 Research and Development, Sales and Marketing Boehringer Ingelheim, EU, nintedanib, pharma

April 22, 2020 Research and Development COVID-19, coronavirus, hydroxychloroquine

April 22, 2020 Research and Development COVID-19, Testing kits, coronavirus, testing swabs

April 22, 2020 Research and Development, Sales and Marketing Cancer, FDA, imbruvica, leukaemia

April 22, 2020 Research and Development COVID-19, coronavirus, hydroxychloroquine

April 21, 2020 Manufacturing and Production, Research and Development Mayzent, Novartis, pharma

April 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, US, feature, generic medicines, generics